drugset / Trial / NCT00003073

Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors

NCT00003073

Phase 1 Unknown 15 enrolled Pacira Pharmaceuticals, Inc
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of liposomal cytarabine in treating young patients who have recurrent or refractory meningeal leukemia, lymphoma, or solid tumors.

Timeline

Start
1997-02
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Cytarabine Small molecule Intrathecal